1294 related articles for article (PubMed ID: 8871057)
1. The role of basophils in allergic disease.
Knol EF; Mul FP; Lie WJ; Verhoeven AJ; Roos D
Eur Respir J Suppl; 1996 Aug; 22():126s-131s. PubMed ID: 8871057
[TBL] [Abstract][Full Text] [Related]
2. Platelet-activating factor induces mediator release by human basophils primed with IL-3, granulocyte-macrophage colony-stimulating factor, or IL-5.
Brunner T; de Weck AL; Dahinden CA
J Immunol; 1991 Jul; 147(1):237-42. PubMed ID: 1711077
[TBL] [Abstract][Full Text] [Related]
3. Degranulation of human basophils by picomolar concentrations of IL-3, IL-5, or granulocyte-macrophage colony-stimulating factor.
Lie WJ; Mul FP; Roos D; Verhoeven AJ; Knol EF
J Allergy Clin Immunol; 1998 May; 101(5):683-90. PubMed ID: 9600507
[TBL] [Abstract][Full Text] [Related]
4. IL-3, IL-5, and granulocyte-macrophage colony-stimulating factor potentiate basophil mediator release stimulated by eosinophil granule major basic protein.
Sarmiento EU; Espiritu BR; Gleich GJ; Thomas LL
J Immunol; 1995 Aug; 155(4):2211-21. PubMed ID: 7543541
[TBL] [Abstract][Full Text] [Related]
5. The effect of interleukin 3 upon IgE-dependent and IgE-independent basophil degranulation and leukotriene generation.
Kurimoto Y; De Weck AL; Dahinden CA
Eur J Immunol; 1991 Feb; 21(2):361-8. PubMed ID: 1705512
[TBL] [Abstract][Full Text] [Related]
6. Biphasic Ca2+ responses in human basophils. Evidence that the initial transient elevation associated with the mobilization of intracellular calcium is an insufficient signal for degranulation.
MacGlashan D; Botana LM
J Immunol; 1993 Feb; 150(3):980-91. PubMed ID: 7678630
[TBL] [Abstract][Full Text] [Related]
7. Human interleukin-3 inhibits the binding of granulocyte-macrophage colony-stimulating factor and interleukin-5 to basophils and strongly enhances their functional activity.
Lopez AF; Eglinton JM; Lyons AB; Tapley PM; To LB; Park LS; Clark SC; Vadas MA
J Cell Physiol; 1990 Oct; 145(1):69-77. PubMed ID: 1698795
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of human basophils results in homotypic aggregation. A response independent of degranulation.
Knol EF; Kuijpers TW; Mul FP; Roos D
J Immunol; 1993 Nov; 151(9):4926-33. PubMed ID: 7691958
[TBL] [Abstract][Full Text] [Related]
9. The degradation product of the C5a anaphylatoxin C5adesarg retains basophil-activating properties.
Bürgi B; Brunner T; Dahinden CA
Eur J Immunol; 1994 Jul; 24(7):1583-9. PubMed ID: 7517876
[TBL] [Abstract][Full Text] [Related]
10. Analyzing histamine release by flow cytometry (HistaFlow): a novel instrument to study the degranulation patterns of basophils.
Ebo DG; Bridts CH; Mertens CH; Hagendorens MM; Stevens WJ; De Clerck LS
J Immunol Methods; 2012 Jan; 375(1-2):30-8. PubMed ID: 21945198
[TBL] [Abstract][Full Text] [Related]
11. Appearance of granulocyte-macrophage colony-stimulating factor activity at allergen-challenged cutaneous late-phase reaction sites.
Massey W; Friedman B; Kato M; Cooper P; Kagey-Sobotka A; Lichtenstein LM; Schleimer RP
J Immunol; 1993 Feb; 150(3):1084-92. PubMed ID: 8423333
[TBL] [Abstract][Full Text] [Related]
12. Signal transduction events in human basophils. A comparative study of the role of protein kinase C in basophils activated by anti-IgE antibody and formyl-methionyl-leucyl-phenylalanine.
Warner JA; MacGlashan DW
J Immunol; 1990 Sep; 145(6):1897-905. PubMed ID: 1697313
[TBL] [Abstract][Full Text] [Related]
13. Histamine release from human basophils induced by platelet activating factor: the role of extracellular calcium, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
Columbo M; Horowitz EM; Kagey-Sobotka A; Lichtenstein LM
J Allergy Clin Immunol; 1995 Feb; 95(2):565-73. PubMed ID: 7531728
[TBL] [Abstract][Full Text] [Related]
14. Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization.
Patella V; Marinò I; Lampärter B; Arbustini E; Adt M; Marone G
J Immunol; 1995 Mar; 154(6):2855-65. PubMed ID: 7533185
[TBL] [Abstract][Full Text] [Related]
15. IgE-dependent IL-4 secretion by human basophils. The relationship between cytokine production and histamine release in mixed leukocyte cultures.
Schroeder JT; MacGlashan DW; Kagey-Sobotka A; White JM; Lichtenstein LM
J Immunol; 1994 Aug; 153(4):1808-17. PubMed ID: 7519213
[TBL] [Abstract][Full Text] [Related]
16. Regulation of human basophil mediator release by cytokines. I. Interaction with antiinflammatory steroids.
Schleimer RP; Derse CP; Friedman B; Gillis S; Plaut M; Lichtenstein LM; MacGlashan DW
J Immunol; 1989 Aug; 143(4):1310-7. PubMed ID: 2473127
[TBL] [Abstract][Full Text] [Related]
17. Hemopoietic growth factors regulate basophil function and viability.
Hirai K; Morita Y; Miyamoto T
Immunol Ser; 1992; 57():587-600. PubMed ID: 1380308
[TBL] [Abstract][Full Text] [Related]
18. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family.
Kuna P; Reddigari SR; Schall TJ; Rucinski D; Sadick M; Kaplan AP
J Immunol; 1993 Mar; 150(5):1932-43. PubMed ID: 7679699
[TBL] [Abstract][Full Text] [Related]
20. Effects of basophil-priming and stimulating cytokines on histamine release from isolated human skin mast cells.
Nitschke M; Sohn K; Dieckmann D; Gibbs BF; Wolff HH; Amon U
Arch Dermatol Res; 1996 Jul; 288(8):463-8. PubMed ID: 8844126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
